ATE159023T1 - Farnesyl-proteintransferase inhibitoren als antikrebsmittel - Google Patents
Farnesyl-proteintransferase inhibitoren als antikrebsmittelInfo
- Publication number
- ATE159023T1 ATE159023T1 AT94909497T AT94909497T ATE159023T1 AT E159023 T1 ATE159023 T1 AT E159023T1 AT 94909497 T AT94909497 T AT 94909497T AT 94909497 T AT94909497 T AT 94909497T AT E159023 T1 ATE159023 T1 AT E159023T1
- Authority
- AT
- Austria
- Prior art keywords
- anticancer agents
- protein transferase
- transferase inhibitors
- farnesyl protein
- alkyl
- Prior art date
Links
- 239000002246 antineoplastic agent Substances 0.000 title 1
- 239000003528 protein farnesyltransferase inhibitor Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 150000001768 cations Chemical class 0.000 abstract 1
- 125000001475 halogen functional group Chemical group 0.000 abstract 1
- 125000001624 naphthyl group Chemical group 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4015—Esters of acyclic unsaturated acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl
- C07F9/3821—Acyclic saturated acids which can have further substituents on alkyl substituted by B, Si, P or a metal
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3826—Acyclic unsaturated acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
- C07F9/4012—Esters of acyclic acids which can have further substituents on alkyl substituted by B, Si, P or a metal
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2141193A | 1993-02-23 | 1993-02-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE159023T1 true ATE159023T1 (de) | 1997-10-15 |
Family
ID=21804071
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT94909497T ATE159023T1 (de) | 1993-02-23 | 1994-01-24 | Farnesyl-proteintransferase inhibitoren als antikrebsmittel |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US5463181A (de) |
| EP (1) | EP0686159B1 (de) |
| JP (1) | JPH08509470A (de) |
| KR (1) | KR100305128B1 (de) |
| CN (1) | CN1045207C (de) |
| AT (1) | ATE159023T1 (de) |
| AU (1) | AU684071B2 (de) |
| CA (1) | CA2154871C (de) |
| DE (1) | DE69406110T2 (de) |
| DK (1) | DK0686159T3 (de) |
| ES (1) | ES2110738T3 (de) |
| FI (1) | FI111369B (de) |
| GR (1) | GR3025499T3 (de) |
| HU (1) | HUT72647A (de) |
| IL (1) | IL108694A0 (de) |
| NO (1) | NO306618B1 (de) |
| NZ (1) | NZ262585A (de) |
| TW (1) | TW265345B (de) |
| ZA (1) | ZA941099B (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002322720B2 (en) | 2001-07-25 | 2008-11-13 | Raptor Pharmaceutical Inc. | Compositions and methods for modulating blood-brain barrier transport |
| FR2833266B1 (fr) * | 2001-12-11 | 2004-10-22 | Mayoly Spindler Lab | Nouveaux derives phosphonates, leur procede de preparation, leur utilisation comme modulateurs de l'activite des lymphocytes tgamma9 delta2 |
| CA2789262C (en) | 2005-04-28 | 2016-10-04 | Proteus Digital Health, Inc. | Pharma-informatics system |
| EP2063905B1 (de) | 2006-09-18 | 2014-07-30 | Raptor Pharmaceutical Inc | Behandlungen von lebererkrankungen durch verabreichung von konjugaten aus rezeptor-assoziierten proteinen |
| TR201908314T4 (tr) | 2009-02-20 | 2019-06-21 | 2 Bbb Medicines B V | Glutatyon bazlı ilaç dağıtım sistemi. |
| KR101909711B1 (ko) | 2009-05-06 | 2018-12-19 | 라보라토리 스킨 케어, 인크. | 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법 |
| US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57142993A (en) * | 1981-02-28 | 1982-09-03 | Sagami Chem Res Center | 2-hydroxyphosphonic diester |
| DE3313070A1 (de) * | 1983-04-12 | 1984-10-18 | Bayer Ag, 5090 Leverkusen | Chlorierte phosphorylmethylcarbonyl-derivate, verfahren zu ihrer herstellung und ihre verwendung in pflanzenschutmitteln |
| DE3425701A1 (de) * | 1984-07-12 | 1986-01-16 | Bayer Ag, 5090 Leverkusen | Verfahren zur herstellung von chlorierten phosphorylmethylcarbonyl-derivaten und neue zwischenprodukte zu ihrer herstellung |
| US4924024A (en) * | 1988-01-11 | 1990-05-08 | E. R. Squibb & Sons, Inc. | Phosphorus-containing squalene synthetase inhibitors, new intermediates and method |
| US5177239A (en) * | 1989-07-18 | 1993-01-05 | E. R. Squibb & Sons, Inc. | Method for preparing a phosphonic acid ester |
| US5298655A (en) * | 1991-09-27 | 1994-03-29 | Merck & Co., Inc. | Farnesyl pyrophosphate analogs |
-
1993
- 1993-11-08 US US08/148,188 patent/US5463181A/en not_active Expired - Fee Related
-
1994
- 1994-01-24 JP JP6518980A patent/JPH08509470A/ja not_active Ceased
- 1994-01-24 NZ NZ262585A patent/NZ262585A/en unknown
- 1994-01-24 KR KR1019950703547A patent/KR100305128B1/ko not_active Expired - Fee Related
- 1994-01-24 AU AU62324/94A patent/AU684071B2/en not_active Ceased
- 1994-01-24 DE DE69406110T patent/DE69406110T2/de not_active Expired - Fee Related
- 1994-01-24 EP EP94909497A patent/EP0686159B1/de not_active Expired - Lifetime
- 1994-01-24 CA CA002154871A patent/CA2154871C/en not_active Expired - Fee Related
- 1994-01-24 CN CN94191274A patent/CN1045207C/zh not_active Expired - Fee Related
- 1994-01-24 DK DK94909497.3T patent/DK0686159T3/da active
- 1994-01-24 AT AT94909497T patent/ATE159023T1/de not_active IP Right Cessation
- 1994-01-24 ES ES94909497T patent/ES2110738T3/es not_active Expired - Lifetime
- 1994-01-24 HU HU9502455A patent/HUT72647A/hu unknown
- 1994-02-17 ZA ZA941099A patent/ZA941099B/xx unknown
- 1994-02-17 IL IL10869494A patent/IL108694A0/xx unknown
- 1994-02-18 TW TW083101358A patent/TW265345B/zh active
-
1995
- 1995-08-22 NO NO953292A patent/NO306618B1/no unknown
- 1995-08-22 FI FI953934A patent/FI111369B/fi active
-
1997
- 1997-11-26 GR GR970403148T patent/GR3025499T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR100305128B1 (ko) | 2001-11-22 |
| ES2110738T3 (es) | 1998-02-16 |
| NO306618B1 (no) | 1999-11-29 |
| HUT72647A (en) | 1996-05-28 |
| EP0686159A1 (de) | 1995-12-13 |
| JPH08509470A (ja) | 1996-10-08 |
| IL108694A0 (en) | 1994-05-30 |
| GR3025499T3 (en) | 1998-02-27 |
| FI111369B (fi) | 2003-07-15 |
| AU6232494A (en) | 1994-09-14 |
| HU9502455D0 (en) | 1995-10-30 |
| DE69406110D1 (de) | 1997-11-13 |
| FI953934L (fi) | 1995-08-22 |
| EP0686159B1 (de) | 1997-10-08 |
| CA2154871A1 (en) | 1994-09-01 |
| DE69406110T2 (de) | 1998-05-14 |
| ZA941099B (en) | 1994-08-30 |
| NO953292D0 (no) | 1995-08-22 |
| CN1118166A (zh) | 1996-03-06 |
| NZ262585A (en) | 1997-12-19 |
| NO953292L (no) | 1995-08-22 |
| US5463181A (en) | 1995-10-31 |
| DK0686159T3 (da) | 1998-01-26 |
| TW265345B (de) | 1995-12-11 |
| CN1045207C (zh) | 1999-09-22 |
| AU684071B2 (en) | 1997-12-04 |
| FI953934A0 (fi) | 1995-08-22 |
| CA2154871C (en) | 1998-04-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO961133L (no) | Hydroksysubstituerte azetidinonforbindelser som kan anvendes som hypokolesterolemiske midler | |
| HU9502973D0 (en) | Aroyl-piperidine derivative | |
| DE69535461D1 (de) | Kalzium-rezeptor aktive verbindungen | |
| MX173274B (es) | Metodos y composiciones biocidas para sistemas de agua recirculante | |
| DK0722492T3 (da) | Stabilisering af proteiner i oplösning | |
| ATE159023T1 (de) | Farnesyl-proteintransferase inhibitoren als antikrebsmittel | |
| NZ329853A (en) | 4-piperidinyl substituted 2-amino indane derivatives and medicaments | |
| NO306617B1 (no) | Oksazolkinolinonderivater og medikament og farmasöytisk preparat derav | |
| AR247750A1 (es) | Sistema inhibidor de polimerizacion y composicion estabilizada que lo comprende. | |
| DE69115440D1 (de) | Calciumborat/Aminocarboxylat-Korrosionsinhibitoren | |
| CS743087A2 (en) | Herbicide and method of its effective substances production | |
| TH42236A (th) | ฟธาลาซีน | |
| HUP9902470A2 (hu) | Bifenil-szulfonil-amino-alkil-karbonsav-származékok és az ezeket tartalmazó gyógyszerkészítmények |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |